Novo Nordisk has reached a settlement with two American institutions selling counterfeit versions of Ozempic
白云追月素
发表于 2024-2-10 15:16:04
269
0
0
Novo Nordisk announced on February 9th that it has reached a settlement with a clinic in Tallahassee, Florida and a spa in Miami, USA. Novo Nordisk accuses these two institutions of engaging in false advertising, trademark infringement, and unfair competition.
Florida court records show that these two institutions have agreed to stop using the Novo Nordisk trademark to sell compound formulations semaglutide, the active ingredient of Novo Nordisk branded drugs, and have agreed to explicitly disclose within 12 months that unapproved compound formulations have not been approved by regulatory authorities in terms of safety, efficacy, or quality, and that versions approved by the US Food and Drug Administration (FDA) are available on the market.
The compensation amount is not listed in the court documents. Novo Nordisk will not disclose any further information.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Alibaba's latest announcement! Reached a settlement agreement on the class action lawsuit of US shareholders
- Boeing Union negotiates with US Department of Labor to restart salary negotiations with Boeing
- The US ITC has officially launched a 337 investigation into TOPCon solar cells, modules, panels, modules, and downstream products
- The US presidential election is approaching and the market is experiencing a huge shock! Traders are watching from the sidelines
- The third largest public pension fund in the United States reduced its holdings of Apple, Nvidia, and others in the third quarter
- High housing prices, average age of US homebuyers jumps to 56 years old
- Boeing workers accept new salary agreement, ending 7-week strike
- The McDonald's E. coli contamination incident in the United States has caused over 100 people to be infected
- The number of employees in Starbucks' US stores continues to decline due to the policy of 'adding stores but not adding people'
- Stellantis suspends production at two factories in Italy
-
11月21日、2024世界インターネット大会烏鎮サミットで、創業者、CEOの周源氏が大会デジタル教育フォーラムとインターネット企業家フォーラムでそれぞれ講演、発言したことを知っている。周源氏によると、デジタル教 ...
- 不正经的工程师
- 昨天 16:36
- 支持
- 反对
- 回复
- 收藏
-
スターバックスが中国事業の株式売却の可能性を検討していることが明らかになった。 11月21日、外国メディアによると、スターバックスは中国事業の株式売却を検討している。関係者によると、スターバックスは中国事 ...
- 献世八宝掌
- 前天 16:29
- 支持
- 反对
- 回复
- 收藏
-
【意法半導体CEO:中国市場は非常に重要で華虹と協力を展開】北京時間11月21日、意法半導体(STM.N)は投資家活動の現場で、同社が中国ウェハー代工場の華虹公司(688347.SH)と協力していると発表した。伊仏半導体 ...
- 黄俊琼
- 前天 14:29
- 支持
- 反对
- 回复
- 收藏
-
【ナスダック中国金龍指数は1%下落した。人気の中概株の多くは下落した】現地時間11月21日、ナスダック中国金龍指数は1%下落し、人気の中概株の多くは下落し、必死に10%超下落し、愛奇芸は7%超下落し、百度は6%近く ...
- 比尔992
- 昨天 11:57
- 支持
- 反对
- 回复
- 收藏